Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1476-3524
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease ; volume:29 ; number:3 ; day:25 ; month:8 ; year:2015 ; pages:351-363 ; date:4.2016
Neurotoxicity research ; 29, Heft 3 (25.8.2015), 351-363, 4.2016

Creator
Wąsik, Agnieszka
Contributor
Romańska, Irena
Michaluk, Jerzy
Zelek-Molik, Agnieszka
Nalepa, Irena
Antkiewicz-Michaluk, Lucyna
SpringerLink (Online service)

DOI
10.1007/s12640-015-9556-6
URN
urn:nbn:de:1111-201604232132
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Wąsik, Agnieszka
  • Romańska, Irena
  • Michaluk, Jerzy
  • Zelek-Molik, Agnieszka
  • Nalepa, Irena
  • Antkiewicz-Michaluk, Lucyna
  • SpringerLink (Online service)

Other Objects (12)

Neuroprotective properties of curcumin in toxin-base animal models of Parkinson’s disease: a systematic experiment literatures review

Neuroprotective properties of curcumin in toxin-base animal models of Parkinson’s disease: a systematic experiment literatures review

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model

Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model

Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

Neurochemical changes in animal models of Parkinson’s disease

Neurochemical changes in animal models of Parkinson’s disease

Biogene Amine in der Pathogenese des Morbus Parkinson

Biogene Amine in der Pathogenese des Morbus Parkinson

Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation

Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation

Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease Patients

Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease Patients

Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease

Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease

Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease

Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease

TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition

TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition

Related objects